Clinical Trial: A Study to Assess Safety, Tolerability and Drug Levels of BMS-986504 in Participants With Advanced Solid Tumors

U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07077434) titled 'A Study to Assess Safety, Tolerability and Drug Levels of BMS-986504 in Participants With Advanced Solid Tumors' on July 21.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability and drug levels of BMS-986504 in participants with advanced solid tumors.

Study Start Date: Oct. 22, 2025

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: DRUG: BMS-986504

Specified dose on specified days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Bristol-Myers Squibb

Disclaimer: Curated by HT Syndication....